Teva's senior notes and debentures and convertible debentures are issued by various special-purpose finance subsidiaries. All such debt is guaranteed by Teva Pharmaceutical Industries Ltd.
Senior Notes and Debentures
Convertible Senior Debentures
To view the prospectus supplement relating to the January 2006 debentures - click here
For conversion and other notices - click here
(1) These convertible senior debentures due 2026 include a "net share settlement" feature according to which the principal of the debentures will be paid in cash and in the case of conversion, only the residual conversion value above the principal will be paid in Teva shares.
Term Loans and Other Facilities
*The following amendment document applies to the term loans and revolving credit facility noted above
|Covenant Amendments – September 2017|
|Covenant Amendments – February 2018|